(CRBG) Corebridge Financial - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US21871X1090

Annuities, Life Insurance, Retirement Plans, Investment Products

CRBG EPS (Earnings per Share)

EPS (Earnings per Share) of CRBG over the last years for every Quarter: "2020-12": -0.33488372093023, "2021-03": 4.831007751938, "2021-06": -0.46976744186047, "2021-09": 2.2015503875969, "2021-12": 4.8403100775194, "2022-03": 5.3658914728682, "2022-06": 4.5007751937984, "2022-09": 3.6370668316832, "2022-12": -0.81239401880684, "2023-03": -0.70528580208974, "2023-06": 1.1821527138914, "2023-09": 3.2776911076443, "2023-12": -2.0679304897314, "2024-03": 1.4050248039686, "2024-06": 0.59582109043421, "2024-09": -2.0166922159768, "2024-12": 3.8021015761821, "2025-03": -1.1899641577061, "2025-06": -1.1993458113756,

CRBG Revenue

Revenue of CRBG over the last years for every Quarter: 2020-12: 2872, 2021-03: 7343, 2021-06: 3687, 2021-09: 5500, 2021-12: 6947, 2022-03: 8104, 2022-06: 7565, 2022-09: 7203, 2022-12: 3794, 2023-03: 4119, 2023-06: 6027, 2023-09: 5858, 2023-12: 2809, 2024-03: 6137, 2024-06: 3614, 2024-09: 1940, 2024-12: 7031, 2025-03: 3590, 2025-06: 737,

Description: CRBG Corebridge Financial

Corebridge Financial, Inc. is a leading provider of retirement solutions and insurance products in the United States, operating through four main segments: Individual Retirement, Group Retirement, Life Insurance, and Institutional Markets. The company offers a diverse range of products, including annuities, life insurance, and investment advisory services, catering to various customer needs.

From a business perspective, Corebridge Financials revenue streams are diversified across its segments, with the Individual Retirement segment likely generating significant revenue from fixed annuities and variable annuities. The Group Retirement segments open architecture recordkeeping platform and in-plan investment advisory services also contribute to revenue growth. Key Performance Indicators (KPIs) to monitor include the companys annuity sales, life insurance policy sales, and assets under management (AUM).

To evaluate Corebridge Financials financial performance, key metrics to analyze include revenue growth, net income margin, return on equity (RoE), and return on assets (RoA). The companys RoE of 5.73% indicates a relatively modest return on shareholder equity. Other important KPIs include the companys capital adequacy ratio, asset quality, and liquidity metrics. Additionally, the companys dividend yield and payout ratio are also worth examining to assess its attractiveness to income-seeking investors.

From a valuation perspective, Corebridge Financials price-to-earnings (P/E) ratio of 30.80x suggests a relatively high valuation compared to its earnings. However, the forward P/E ratio of 7.05x indicates expected earnings growth. To further assess the companys valuation, metrics such as price-to-book (P/B) ratio, enterprise value-to-EBITDA (EV/EBITDA) ratio, and dividend yield can be analyzed.

CRBG Stock Overview

Market Cap in USD 18,723m
Sub-Industry Diversified Financial Services
IPO / Inception 2022-09-15

CRBG Stock Ratings

Growth Rating 84.6%
Fundamental 40.2%
Dividend Rating 55.5%
Return 12m vs S&P 500 6.13%
Analyst Rating 4.07 of 5

CRBG Dividends

Dividend Yield 12m 3.63%
Yield on Cost 5y 7.09%
Annual Growth 5y 25.99%
Payout Consistency 58.5%
Payout Ratio 37.0%

CRBG Growth Ratios

Growth Correlation 3m -9.9%
Growth Correlation 12m 73.1%
Growth Correlation 5y 91.5%
CAGR 5y 26.36%
CAGR/Max DD 3y 0.75
CAGR/Mean DD 3y 3.84
Sharpe Ratio 12m 0.71
Alpha 13.57
Beta 0.674
Volatility 27.68%
Current Volume 4130.1k
Average Volume 20d 2729.4k
Stop Loss 32.3 (-3.1%)
Signal -1.17

Piotroski VR‑10 (Strict, 0-10) 1.0

Net Income (-337.0m TTM) > 0 and > 6% of Revenue (6% = 797.9m TTM)
FCFTA 0.00 (>2.0%) and ΔFCFTA -0.40pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 368.3% (prev 352.2%; Δ 16.13pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.00 (>3.0%) and CFO 1.68b > Net Income -337.0m (YES >=105%, WARN >=100%)
Net Debt (9.17b) to EBITDA (704.0m) ratio: 13.02 <= 3.0 (WARN <= 3.5)
Current Ratio 6.18 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (550.3m) change vs 12m ago -10.17% (target <= -2.0% for YES)
Gross Margin 95.77% (prev 98.34%; Δ -2.57pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 3.40% (prev 4.82%; Δ -1.41pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 0.75 (EBITDA TTM 704.0m / Interest Expense TTM 563.0m) >= 6 (WARN >= 3)

Altman Z'' 0.98

(A) 0.12 = (Total Current Assets 58.44b - Total Current Liabilities 9.46b) / Total Assets 399.16b
(B) 0.04 = Retained Earnings (Balance) 17.67b / Total Assets 399.16b
(C) 0.00 = EBIT TTM 424.0m / Avg Total Assets 390.83b
(D) 0.02 = Book Value of Equity 7.04b / Total Liabilities 385.99b
Total Rating: 0.98 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 40.21

1. Piotroski 1.0pt = -4.0
2. FCF Yield 4.75% = 2.38
3. FCF Margin 12.62% = 3.15
4. Debt/Equity 1.68 = 1.23
5. Debt/Ebitda 29.41 = -2.50
6. ROIC - WACC -2.94% = -3.68
7. RoE -2.73% = -0.46
8. Rev. Trend -54.54% = -2.73
9. Rev. CAGR -56.35% = -2.50
10. EPS Trend -27.50% = -0.69
11. EPS CAGR 0.0% = 0.0

What is the price of CRBG shares?

As of September 15, 2025, the stock is trading at USD 33.35 with a total of 4,130,132 shares traded.
Over the past week, the price has changed by -0.77%, over one month by -2.60%, over three months by +3.12% and over the past year by +25.51%.

Is Corebridge Financial a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Corebridge Financial (NYSE:CRBG) is currently (September 2025) a stock to sell. It has a ValueRay Fundamental Rating of 40.21 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CRBG is around 37.20 USD . This means that CRBG is currently undervalued and has a potential upside of +11.54% (Margin of Safety).

Is CRBG a buy, sell or hold?

Corebridge Financial has received a consensus analysts rating of 4.07. Therefore, it is recommended to buy CRBG.
  • Strong Buy: 6
  • Buy: 5
  • Hold: 2
  • Sell: 0
  • Strong Sell: 1

What are the forecasts/targets for the CRBG price?

Issuer Target Up/Down from current
Wallstreet Target Price 41.2 23.4%
Analysts Target Price 41.2 23.4%
ValueRay Target Price 39.9 19.7%

Last update: 2025-09-01 04:39

CRBG Fundamental Data Overview

Market Cap USD = 18.72b (18.72b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 4.10b USD (Cash And Short Term Investments, last quarter)
P/E Forward = 7.3368
P/S = 1.164
P/B = 1.5219
Beta = 0.956
Revenue TTM = 13.30b USD
EBIT TTM = 424.0m USD
EBITDA TTM = 704.0m USD
Long Term Debt = 11.25b USD (from longTermDebt, last quarter)
Short Term Debt = 9.46b USD (from shortTermDebt, last quarter)
Debt = 20.70b USD (Calculated: Short Term 9.46b + Long Term 11.25b)
Net Debt = 9.17b USD (from netDebt column, last quarter)
Enterprise Value = 35.33b USD (18.72b + Debt 20.70b - CCE 4.10b)
Interest Coverage Ratio = 0.75 (Ebit TTM 424.0m / Interest Expense TTM 563.0m)
FCF Yield = 4.75% (FCF TTM 1.68b / Enterprise Value 35.33b)
FCF Margin = 12.62% (FCF TTM 1.68b / Revenue TTM 13.30b)
Net Margin = -2.53% (Net Income TTM -337.0m / Revenue TTM 13.30b)
Gross Margin = 95.77% ((Revenue TTM 13.30b - Cost of Revenue TTM 563.0m) / Revenue TTM)
Tobins Q-Ratio = 5.02 (Enterprise Value 35.33b / Book Value Of Equity 7.04b)
Interest Expense / Debt = 0.66% (Interest Expense 137.0m / Debt 20.70b)
Taxrate = 21.41% (600.0m / 2.80b)
NOPAT = 333.2m (EBIT 424.0m * (1 - 21.41%))
Current Ratio = 6.18 (Total Current Assets 58.44b / Total Current Liabilities 9.46b)
Debt / Equity = 1.68 (Debt 20.70b / last Quarter total Stockholder Equity 12.30b)
Debt / EBITDA = 29.41 (Net Debt 9.17b / EBITDA 704.0m)
Debt / FCF = 12.34 (Debt 20.70b / FCF TTM 1.68b)
Total Stockholder Equity = 12.34b (last 4 quarters mean)
RoA = -0.08% (Net Income -337.0m, Total Assets 399.16b )
RoE = -2.73% (Net Income TTM -337.0m / Total Stockholder Equity 12.34b)
RoCE = 1.80% (Ebit 424.0m / (Equity 12.34b + L.T.Debt 11.25b))
RoIC = 1.37% (NOPAT 333.2m / Invested Capital 24.36b)
WACC = 4.31% (E(18.72b)/V(39.43b) * Re(8.50%)) + (D(20.70b)/V(39.43b) * Rd(0.66%) * (1-Tc(0.21)))
Shares Correlation 3-Years: -81.82 | Cagr: -1.45%
Discount Rate = 8.50% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 77.74% ; FCFE base≈2.26b ; Y1≈2.44b ; Y5≈2.99b
Fair Price DCF = 89.01 (DCF Value 47.93b / Shares Outstanding 538.5m; 5y FCF grow 8.53% → 3.0% )
Revenue Correlation: -54.54 | Revenue CAGR: -56.35%
Rev Growth-of-Growth: -38.35
EPS Correlation: -27.50 | EPS CAGR: 0.0%
EPS Growth-of-Growth: -96.45

Additional Sources for CRBG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle